Literature DB >> 1711570

Membrane cofactor protein of the complement system: alternative splicing of serine/threonine/proline-rich exons and cytoplasmic tails produces multiple isoforms that correlate with protein phenotype.

T W Post1, M K Liszewski, E M Adams, I Tedja, E A Miller, J P Atkinson.   

Abstract

Membrane cofactor protein (MCP) is a complement regulatory protein that is expressed on human cells and cell lines as two relatively broad species with Mr of 58,000-68,000 and 48,000-56,000. The structure of a previously reported cDNA clone indicated that MCP was a type 1 membrane glycoprotein and a member of the regulators of complement activation gene/protein cluster. However, it did not provide an explanation for the unusual phenotypic pattern of MCP. Therefore, in parallel with an analysis of the gene, additional cDNAs were cloned and characterized. Six different MCP cDNA classes were identified. All encode the same 5' untranslated signal peptide, four SCRs, transmembrane domain, and basic amino acid anchor. However, they differ in the length and composition of an extracellular serine/threonine/proline (STP)-rich area, a site of heavy O-glycosylation, and cytoplasmic tail. Analysis of the MCP gene demonstrated that the variation in cDNA structure was a result of alternative splicing. Peripheral blood cells and cell lines predominantly expressed four of the six isoforms. These varied by the presence or absence of an STP-rich segment of 15 amino acids (STPB) and by the use of one of two cytoplasmic domains. Analysis by polymerase chain reaction, Northern blots, and transfection indicated that the predominance of MCP cDNA isoforms with STPB correlated with the high molecular weight protein phenotype, while the predominance of isoforms without STPB correlated with the lower molecular weight phenotype. The expression in a single cell of four distinct protein species with variable STP-rich regions and cytoplasmic tails represents an interesting example of the use of alternative splicing to provide variability in a mammalian protein.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1711570      PMCID: PMC2118878          DOI: 10.1084/jem.174.1.93

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  40 in total

1.  Characterization of the human trophoblast-leukocyte antigenic molecules defined by a monoclonal antibody.

Authors:  P L Stern; N Beresford; S Thompson; P M Johnson; P D Webb; N Hole
Journal:  J Immunol       Date:  1986-09-01       Impact factor: 5.422

2.  Membrane cofactor protein of the complement system. A HindIII restriction fragment length polymorphism that correlates with the expression polymorphism.

Authors:  N S Bora; T W Post; J P Atkinson
Journal:  J Immunol       Date:  1991-04-15       Impact factor: 5.422

3.  Membrane cofactor protein of complement is present on human fibroblast, epithelial, and endothelial cells.

Authors:  T McNearney; L Ballard; T Seya; J P Atkinson
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

4.  Effects of O-linked glycosylation on the cell surface expression and stability of decay-accelerating factor, a glycophospholipid-anchored membrane protein.

Authors:  P Reddy; I Caras; M Krieger
Journal:  J Biol Chem       Date:  1989-10-15       Impact factor: 5.157

5.  Distribution of membrane cofactor protein of complement on human peripheral blood cells. An altered form is found on granulocytes.

Authors:  T Seya; L L Ballard; N S Bora; V Kumar; W Cui; J P Atkinson
Journal:  Eur J Immunol       Date:  1988-08       Impact factor: 5.532

6.  Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteins.

Authors:  I W Caras; M A Davitz; L Rhee; G Weddell; D W Martin; V Nussenzweig
Journal:  Nature       Date:  1987 Feb 5-11       Impact factor: 49.962

7.  Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement.

Authors:  M E Medof; D M Lublin; V M Holers; D J Ayers; R R Getty; J F Leykam; J P Atkinson; M L Tykocinski
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

8.  Functional properties of membrane cofactor protein of complement.

Authors:  T Seya; J P Atkinson
Journal:  Biochem J       Date:  1989-12-01       Impact factor: 3.857

9.  Identification of a third component of complement-binding glycoprotein of human platelets.

Authors:  G H Yu; V M Holers; T Seya; L Ballard; J P Atkinson
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

10.  Organization of the genes encoding complement receptors type 1 and 2, decay-accelerating factor, and C4-binding protein in the RCA locus on human chromosome 1.

Authors:  M C Carroll; E M Alicot; P J Katzman; L B Klickstein; J A Smith; D T Fearon
Journal:  J Exp Med       Date:  1988-04-01       Impact factor: 14.307

View more
  50 in total

1.  Artificial mutations and natural variations in the CD46 molecules from human and monkey cells define regions important for measles virus binding.

Authors:  E C Hsu; R E Dörig; F Sarangi; A Marcil; C Iorio; C D Richardson
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Identification and characterization of a silencer regulatory element in the 3'-flanking region of the murine CD46 gene.

Authors:  M Nomura; A Tsujimura; N A Begum; M Matsumoto; H Wabiko; K Toyoshima; T Seya
Journal:  Biochem J       Date:  2000-10-15       Impact factor: 3.857

3.  Novel replication-incompetent vector derived from adenovirus type 11 (Ad11) for vaccination and gene therapy: low seroprevalence and non-cross-reactivity with Ad5.

Authors:  Lennart Holterman; Ronald Vogels; Remko van der Vlugt; Martijn Sieuwerts; Jos Grimbergen; Jorn Kaspers; Eric Geelen; Esmeralda van der Helm; Angelique Lemckert; Gert Gillissen; Sandra Verhaagh; Jerome Custers; David Zuijdgeest; Ben Berkhout; Margreet Bakker; Paul Quax; Jaap Goudsmit; Menzo Havenga
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

Review 4.  Separation of self from non-self in the complement system: a role for membrane cofactor protein and decay accelerating factor.

Authors:  J P Atkinson; T J Oglesby; D White; E A Adams; M K Liszewski
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

5.  Structural variations in species B adenovirus fibers impact CD46 association.

Authors:  Lars Pache; Sangita Venkataraman; Vijay S Reddy; Glen R Nemerow
Journal:  J Virol       Date:  2008-06-04       Impact factor: 5.103

Review 6.  Complement's hidden arsenal: New insights and novel functions inside the cell.

Authors:  M Kathryn Liszewski; Michelle Elvington; Hrishikesh S Kulkarni; John P Atkinson
Journal:  Mol Immunol       Date:  2017-02-10       Impact factor: 4.407

7.  Establishment of a human DAF/HRF20 double transgenic mouse line is not sufficient to suppress hyperacute rejection.

Authors:  C Koike; K Isobe; I Nakashima; H Okada; S Hayashi; I Yokoyama; H Takagi
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

Review 8.  Complement regulation and kidney diseases: recent knowledge of the double-edged roles of complement activation in nephrology.

Authors:  Masashi Mizuno; Yasuhiro Suzuki; Yasuhiko Ito
Journal:  Clin Exp Nephrol       Date:  2017-03-24       Impact factor: 2.801

9.  Loxosceles spider venom induces metalloproteinase mediated cleavage of MCP/CD46 and MHCI and induces protection against C-mediated lysis.

Authors:  Carmen W Van Den Berg; Rute M Gonçalves De Andrade; Fabio C Magnoli; Kevin J Marchbank; Denise V Tambourgi
Journal:  Immunology       Date:  2002-09       Impact factor: 7.397

10.  Structure of the extracellular portion of CD46 provides insights into its interactions with complement proteins and pathogens.

Authors:  B David Persson; Nikolaus B Schmitz; César Santiago; Georg Zocher; Mykol Larvie; Ulrike Scheu; José M Casasnovas; Thilo Stehle
Journal:  PLoS Pathog       Date:  2010-09-30       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.